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INTRODUCTION
Tuberculosis has great political and economic
importance both in Nigeria and in the world as a whole.
The global burden of the disease is huge.1 The
identification of infectious patients is one of the key
aspects of tuberculosis control. This is because each
individual with untreated smear positive tuberculosis
infects 10-15 persons per year. 2 A significant
proportion of new cases of tuberculosis are sputum
smear positive. WHO estimates show that close to
50% of new cases of tuberculosis in 2004 were sputum
smear positive.2
Based on the estimated number of incident cases of
tuberculosis, Nigeria ranked fifth in the WHO Africa
Region in 2006.3 The Tuberculosis Laboratory at the
University College Hospital (UCH), the location of
this study, has a pivotal role to play in ensuring quality-
assured bacteriology as part of  the WHO Stop TB
Strategy 4 in that it is one of  the six (6) zonal reference
laboratories for Tuberculosis in Nigeria. It serves the
South-West zone of  Nigeria.3
In Nigeria, while the case notification rate for
tuberculosis has become satisfactory, the case detection
rate, even within Directly Observed Treatment Short
course (DOTS) areas, is still below the target of 70%3,4,
hence there is need for a study to audit the diagnostic
methods most commonly used.
There are a number of studies from the UCH, Ibadan
and other centres in Nigeria describing the peculiarities
of  tuberculosis in various medical sub-specialties.
However, there has been no previous study to audit
the diagnostic service for tuberculosis at the UCH.
In spite of new technologies5,6,7,8 for diagnosing
tuberculosis, AFB microscopy and culture still
constitute the mainstay of the diagnostic procedure
for tuberculosis at the UCH. The Tuberculosis
Laboratory at the UCH, Ibadan has the BACTEC-
460 and MGIT (Mycobacteria Growth Indicator Tube)
broth media available with efforts being made to
acquire facilities for the molecular diagnosis of
tuberculosis.
The global strategy for the control of  tuberculosis,
DOTS identifies cases by AFB microscopy only,4, 9 this
has the advantage of early commencement of
treatment. In view of this, it is imperative that AFB
microscopy is studied, standardized and its specificity
and sensitivity against a more accurate method such as
culture determined.
Our aim was to audit the processes for diagnosing
tuberculosis in our resource-limited setting with the
aim of  improving our services and ensuring that the
best possible service is rendered to our tuberculosis
patients. We hope that this would ultimately improve
the case detection rate for tuberculosis at the UCH
and other parts of Nigeria.
MATERIALS AND METHODS
This was a retrospective study that was carried out in
October 2007 recruiting the most recent patients for
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whom both AFB microscopy and culture had been
done, the specimens were examined within the period
from January 1996 to December 1998, as routine
mycobacterial culture was discontinued shortly after
this period.  The laboratory records of all suspected
cases of tuberculosis for which requests had been
received at the Tuberculosis Laboratory of  the
Department of  Medical Microbiology and
Parasitology of  the UCH, Ibadan were retrieved.
Patient selection
We recruited into the study only those patients who
fulfilled the 2006 WHO requirements for the diagnosis
of  tuberculosis in resource-limited countries.10 This
included patients who had at least 2 specimens (sputum,
pleural aspirate, bronchial washings) sent for the
diagnosis of suspected pulmonary TB and those with
at least 1 sample sent for the diagnosis of extra-
pulmonary TB.  By the above WHO specifications,10
patients were considered positive for TB if at least 1
out of 2 or more specimens sent for AFB microscopy
was found positive for TB hence, patients who had
only 1 sample sent for the diagnosis of suspected
pulmonary TB were recruited only if this was positive
for TB or from an extrapulmonary site.
The protocol for the diagnosis of pulmonary TB in
UCH during the period the samples were obtained
was to examine 3 sputum smear specimens, preferably
early morning sputum specimens sent on consecutive
days. The WHO requirement at the time was for at
least 2 of these 3 specimens to be positive for AFB
for a diagnosis of pulmonary TB to be made.  It has
however been shown by several studies that the
incremental yield with the 3rd smear is not significant
enough to justify the increased workload resulting
therefrom, and that 2 pulmonary-related specimens
were sufficient for a diagnosis of  TB. 11, 12
Patients with multiple specimens sent for the diagnosis
of TB had further analysis of the results of only those
specimens within the same presentation defined as
specimens sent all within the period of 1 week. The
demographic data and details about the results of AFB
microscopy and culture were obtained and patients
with incomplete records were excluded.
Laboratory processes
Specimens from sputum and other non-sterile sites
were decontaminated with 5% sodium hypochlorite
solution (household bleach, JIK™, trademark Reckitt
Benckiser) before centrifugation.  Specimens from
sterile sites such as cerebrospinal fluid were directly
centrifuged and then subjected to Hot Ziehl-Neelsen
(ZN) staining with 1% carbolfuchsin solution.13
Centrifugation was done at 3500g with the CRU 5000
model centrifuge manufactured by IEC.
Examination of smears made from diagnostic
specimens for acid fast bacilli (AFB) was done by 2
different medical laboratory scientists using binocular
microscopes with oil immersion objectives.  At least
one length of a 20 mm long smear is examined
carefully. This corresponds to 100 high power fields
(HPF’s) examined at 1000x magnification.11 Positivity
on AFB microscopy was recorded as scanty or
numerous AFB.  These correspond to 1-9 AFB/1
length or 100HPF and >10AFB/1 length or 100HPF
respectively. Numerous AFB on microscopy
corresponds to 1+, 2+ or 3+ positivity according to
the IUATLD and WHO grading scales.11 5% of  the
slides reviewed weekly were selected in a random but
systematic manner for re-checking.
The processed specimens were then cultured directly
onto Lowenstein-Jensen (L-J) culture medium6 and
Pyruvic Acid Egg Medium (PAEM), a modification
of the L-J medium in which glycerol is replaced by
pyruvic acid to enhance the growth of M. Bovis13.
Incubation was at 37oC for up to 8 weeks.  The cultures
were checked weekly for the growth of mycobacteria.
The internal quality control measures used to confirm
that the organism identified is mycobacterium
tuberculosis include the reduction of nitrates to nitrites,
the production of serpentine cords on smears from
in-vitro grown colonies and the lack of pigment
production in the dark or in the light.5, 6
Interpretation of  results
Detection of  AFB in a sputum smear is not affirmative
for M. tuberculosis because some non-tuberculous
mycobacteria (NTM), otherwise known as atypical
mycobacteria or mycobacteria other than tuberculosis
(MOTT) also cause pulmonary disease and may be
found as the cause of disease or existing in supplying
water as contaminants.7 Non-tuberculous myco-
bacteria, though less pathogenic than M. tuberculosis, can
cause disease at various sites as well as disseminated
disease in immunocompromised hosts. 8 The
recognition of atypical mycobacteria has significant
implications for treatment in that first-line anti-
tuberculous agents are much less active against M.  avium
intercellulare (MAI), an atypical mycobacterial species,
than against M. tuberculosis. In the 1997, American
Thoracic Society (ATS) recommendations for MAI
lung disease, clarithromycin replaces isoniazid and
rifabutin is used in place of rifampicin.  Therapy for
pulmonary disease is usually given until culture has been
negative for 12 months.8 Positive smear results, if  the
AFB found are M. tuberculosis, indicate that the patient
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is highly infectious.7 Negative smear results do not
exclude the presence of less than 10,000 organisms/
ml of sputum.  AFB microscopy also tends to be
negative in specimens from extra-pulmonary sites 2.
AFB microscopy is therefore, not conclusive for the
diagnosis in case of positive findings, and it is not
sensitive enough for exclusion of tuberculosis when
the results are negative.7
The current “gold standard” for the diagnosis of
tuberculosis is mycobacterial culture.  Culture is about
500 times more sensitive than AFB microscopy and
provides organisms for further investigations including
drug susceptibility testing and genotyping.7
Statistics
The data collected were then analyzed using the
Statistical Package for the Social Sciences (SPSS),
Windows version 17.0.
RESULTS
A total of 694 specimens were received from 333
patients. There was 1 specimen each from 108 patients,
2 specimens each from 89 patients, and 3 specimens
each from 136 patients.  One hundred and twenty-
nine (38.7%) of these patients were found to be
positive. 78 (60.5%) were positive on AFB microscopy
alone, 13 (10.0%) on culture alone and 38 (29.5%) on
both culture and AFB microscopy.  The actual age
was stated for 87 of  the cases positive for TB.  The
age range was 8 to 72 years with peak occurrence in
the third decade of life.
The sex was recorded for all the positive cases.  Sixty-
eight (68, 52.7%) of these patients were females and
61 (47.3%) were males giving a male to female ratio
of 0.9 to 1.
One hundred and sixteen of the 129 positive cases
were positive by AFB microscopy while 13 patients
were negative.  Seventy-four (63.8%) of them had
scanty AFB, 42 of  them (36.2%) had numerous AFB.
The 13 AFB-negative cases were found to be positive
on culture thus, justifying their inclusion in the study
for further assessment.
Fifty-one (39.5%) of the 129 positive cases had positive
culture results while 78 (60.5%) had negative results.
Out of the 51 cases which were found to be positive
on culture, 38 cases (74.5%) grew on Lowensen-Jensen
culture medium alone, 10 (19.6%) grew on Pyruvic
Acid Enhanced Medium (PAEM) while 3 (5.9%) grew
on both culture media.
Smears showing numerous AFB were not more likely
to show positive results on culture, smears with scanty
AFB showed positive cultures in 37.8% while smears
with numerous AFB on ZN staining showed positive
cultures in 23.8% of  cases.
When compared to culture, AFB microscopy was
found to have a diagnostic specificity of 71.6% and a
diagnostic sensitivity of 74.5%.
DISCUSSION
In this study, a total of  13 cases were negative on AFB
microscopy but positive on culture, this constituted
25.5% of the total of 51 cases which were positive on
culture. A negative culture report on an AFB smear
positive specimen may indicate the presence of non-
cultivable bacilli.7
Seventy-eight (78) cases were negative on culture even
though they had been found to be positive on AFB
microscopy. This constituted 67.2% of  the total of
116 cases which were positive on AFB microscopy. A
negative culture report on AFB positive specimen is
typical for patients undergoing successful therapy.7
With the recommended 6-month regimen, virtually all
patients will have negative sputum cultures by the end
of the third month.  In some patients, especially those
with cavitary disease and large numbers of organisms,
AFB sputum conversion may follow culture
conversion. This phenomenon is presumably due to












Scanty AFB 28 (54.9%) 46 (16.7%) 74 (22.7%)
Numerous AFB 10 (19.6%) 32 (11.6%) 42 (12.9%)
Negative 13 (25.5%) 197 (71.7%) 210 (64.4%)
TOTAL 51 275 326
Table 1- Correlation of  results of  AFB microscopy with culture
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We did not find complete agreement in the results
obtained from mycobacterial culture and AFB
microscopy at the Tuberculosis Laboratory at UCH.
We could not ascertain the specific causes of  the
disparities seen as this is a retrospective study.  Some
of the disparities found in the results of AFB
microscopy and culture can be explained by laboratory
errors.  A previous study shows that false positive
results on AFB microscopy may be due to clerical
errors, serious microscope malfunction, grossly
inadequate technique or inability to recognize acid fast
bacilli due to inadequate training or high staff  turnover.2
False negative results on AFB microscopy may suggest
work overload, poor staining reagents or technique,
inadequate microscopes, incorrect reading or
carelessness. 2 False negative results on culture may be
due to long specimen transport time, the lack of
sufficient technical efficiency, poor decontamination
or culture preparation, use of expired or poorly
prepared media, poor interpretation of findings and
incorrect data recording.11 False positive results on
culture have been described following cross-
contamination in the laboratory.7
The percentages for positivity with AFB microscopy
compared with culture obtained in this study may be
compared with those from various parts of the
world.14
Cases with numerous AFB on microscopy did not
show an increased likelihood for yielding positive
results on culture than those with scanty AFB. This is
due to the fact that the recovery of AFB from
microscopy is significantly affected by several factors
including the adequacy of the specimen, the processes
of collection, transport and decontamination of the
specimen, the temperature of centrifugation and the
amount of centrifugal force applied.7
The revised definition of a new sputum smear-positive
pulmonary tuberculosis case is based on the presence
of at least one acid fast bacillus (AFB+) in at least one
sputum sample in countries with a well functioning
external quality assurance (EQA) system.15 Hence, both
cases with scanty and numerous AFB on microscopy
will be considered  as pulmonary tuberculosis cases
according to WHO specifications, provided there is
an EQA program in the laboratory.
In resource-limited settings where tuberculosis is most
prevalent, where facilities for mycobacterial culture is
not readily available in most laboratories, and where
the need to cut cost is paramount, it is possible to
depend mostly upon AFB microscopy without the
need for confirmation by culture for every index case.
However, we are able to depend on AFB microscopy
alone for diagnosis only to the extent that we are
convinced that results therefrom are accurate. Culture
may then be reserved for paediatric cases, cases of
extra-pulmonary disease, sputum smear negative TB
with HIV co-infection.3
The WHO new policy requires that a well functioning
EQA system must be in place.  In truth, this is the
most important consideration because unless there is
a process whereby we can ensure that each case
diagnosed by AFB microscopy is truly positive and
not a false positive case, there will be a continued need
for culture to be done for confirmation.  This means
that in our resource-limited setting, our efforts should
be directed most importantly towards assuring quality
in the use of  AFB microscopy.
In order to simplify and standardize EQA activities
for AFB microscopy, and to prioritize EQA at National
TB Control Programs (NTP), a practical EQA
guideline was developed by an international working
group and endorsed in 2002. These international EQA
guidelines recommend three methods to evaluate
laboratory performance: on-site assessment using a
standardized questionnaire, panel testing of technician
proficiency using centrally prepared slides, and blinded
rechecking of a random sample of routine slides from
each peripheral laboratory.2 These EQA processes for
AFB microscopy have become operational in our
laboratory at the UCH, Ibadan.
All the cases recruited into this study showed growth
on culture within a period ranging between 3 and 8
weeks with an average duration period to growth of
4.8 weeks.  Seven (7) cases were identified in the records
which showed growth on culture within 1 week. These
are not cases of  tuberculosis as the confirmatory tests
enumerated in the materials and methods section above
were negative in these cases.  Tuberculosis is caused by
bacteria belonging to the Mycobacterium tuberculosis
complex (M tuberculosis, M bovis and M. africanum ) which
are slow-growing.    Rapidly growing mycobacteria
(RGM) are the Runyon group IV organisms that usually
form colonies within 7 days of  incubation as opposed
to slow-growing mycobacteria, that is, Runyon groups
I, II, and III and the M tuberculosis complex group, that
require longer incubation periods. RGM, though
traditionally believed to be non-pathogenic or
opportunistic species, have emerged as significant
human pathogens, causing various infections in healthy
and immunocompromised hosts.16 This underscores
the importance of the accurate interpretation of
findings on culture and the use of  confirmatory tests.
The recognition of RGM has significant implications
for treatment purposes. These organisms are resistant
to anti-tuberculous agents other than amikacin, but are
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variably susceptible to several other antibiotics, the most
useful of which is clarithromycin.8
Both L-J and PAEM are able to support the growth
of M tuberculosis though growth is much better on L-
J medium than on PAEM. Our presumption is that
the cases which grew on only L-J or both L-J and
PAEM are likely cases of M. tuberculosis and those which
grew on only PAEM are likely cases of M. bovis with a
suggestion of  a likely prevalence as high as 19.6% .  It
is said that M. bovis has become rare, both in developed
and developing countries.5,8 There is need for the
speciation of  subsequent isolates to determine the
particular strain of mycobacteria causing disease in each
case. Speciation can be done by the use of biochemical
tests, liquid media with radiometric growth detection,
nucleic acid probes and High Perfomance Liquid
Chromatography (HPLC) of  mycolic acids.8
AFB microscopy is shown in this study to have a
diagnostic specificity of 71.6% and a sensitivity of
74.5%. Previous studies from other developing
countries showed higher specificity and sensitivity values
for AFB microscopy. Shea et al 17 showed a specificity
of 100% and a sensitivity of 93.1% in Uganda while
Farnia et al 18 showed a specificity of 96% and a
sensitivity of 78% in Iran.  These results were obtained
with similar procedures.
Modification of laboratory processes,2 re-training of
personnel, supply of new microscopes, and the
implementation of  EQA programs have been shown
to significantly increase the accuracy of  TB diagnosis.
CONCLUSION
An important first step in the microbiological diagnosis
of  tuberculosis is the clinician’s suspicion and the
requisition of  investigations.
In general, there is need for training and re-training
(continuing education) of medical laboratory scientists
to improve smear and culture preparation, staining and
reading techniques as well as the provision and the
maintenance of necessary equipment such as
microscopes.
If AFB microscopy is to be done routinely without
confirmation by culture in our resource-limited setting,
then the overriding need is for quality to be fully assured
in its use.
Acknowledgements
The authors acknowledge the contributions of  Mr F.A.
Obaseki and Mr A.O. Adebiyi, both medical laboratory
scientists for their technical assistance.
REFERENCES
1. Wambani SJ & Reeve P. Tuberculosis. In The
Imaging of Tropical Diseases, with Epidemiological,
Pathological and Clinical Correlation. 2nd Edition. (ed.
Palmer P. and Reeder M.) Springer –Verlag , USA.
2001; Chapter 5.
2. Van Rie A, Fitzgerald D, Kabuya G, et al (2008)
Sputum smear microscopy: evaluation of the
impact of training, microscope distribution, and
the use of External Quality Assessment Guidelines
for resource poor settings. J. Clin. Microbiol.
doi:10.1128/JCM.01553-07.
3. World Health Organization (WHO). Global
Tuberculosis Control: Country Profile for Nigeria,
WHO report 2008; 129-132 © World Health
Organization, Geneva.
4. World Health Organization (WHO) The Stop
Tuberculosis strategy, pages 3-5 © World Health
Organization, Geneva. 2006
5. Brooks GF, Butel JS, Morse SA. Mycobacteria.
In Jawetz, Melnick, & Adelberg’s Medical Microbiology.
23rd edn. (ed. G.F. Brooks, J.S. Butel, S.A.
Morse)The McGraw-Hill Companies Inc., Asia.
2004; Chapter 24, 319- 326.
6. Cheesbrough M. Mycobacterium tuberculosis. In
District Laboratory Practice in Tropical Countries (Part
2). 1st edn. (ed M. Cheesbrough) Cambridge
University Press, India. 2000; 209.
7. Zwolska Z  Modern microbiological diagnostic
methods of tuberculosis in clinical practice, 2005;
70-71.
8. Raviglione M.C. & O’Brien R.J. Section 8
Mycobacterial diseases. Chapters 168 (Antimyco-
bacterial agents) & 169 (Tuberculosis). In Harrison’s
Principles of  Internal Medicine.  15th edn. (ed.
Braunwald E, Fauci A.S, Kasper D.L., Hauser S.L.,
Longo D.L., Jameson J.L.) McGraw-Hill
Companies, Inc, USA. 2001; 1017-1034.
9. Osho J.A.  Treatment of  opportunistic infections
of HIV with reference to tuberculosis mana-
gement (powerpoint presentation) 2006. Available
at http://www.nelanigeria.org/otherpages/
conferences-recent1.html.
10. Improving the diagnosis and treatment of smear-
negative pulmonary and extrapulmonary
tuberculosis among adults and adolescents.
Recommendations for HIV-prevalent and
resource-constrained settings. Stop TB
Department, Department of  HIV/AIDS, World
Health Organisation. WHO, Geneva, Switzerland,
2006, available at http://www.who.int/entity/tb/
publications/2006/tbhiv_recommendations.pdf
11. Reider HL, Van Deun A, Kam KM, et al: Table
II.3. Grading scales for bright field (Ziehl-Neelsen)
and fluorescence microscopy, Priorities for
Tuberculosis Bacteriology Services in Low-
                                                   Annals of Ibadan Postgraduate  Medicine. Vol. 9 No. 1 June, 2011    29
income countries. International Union Against
Tuberculosis and Lung Disease 2nd Edition 2007.
12. Improving the Diagnosis of  Tuberculosis through
Optimization of  Sputum Microscopy. Expert
Consultation. World Health Organization ©WHO
2005
13. Ziehl Neelsen staining: International Union against
Tuberculosis (IUAT), Technical Guide for sputum
Examination for Tuberculosis by Direct
Microscopy. Bulletin of  the International Union
Against Tuberculosis, supplement No.2, 1978.
14. Ridderhof J: AFB smears for diagnosis and
monitoring treatment . © Division of laboratory
systems, Public Health Practice Program Office,
Centers for Disease Control and Prevention.
Available at http://wwwn.cdc.gov/dls/ila/cd/
india/Jan22.
15. World Health Organization (WHO) New WHO
policies: Definition of a new sputum smear-
positive tuberculosis case, 2009;  2 © World Health
Organization, Geneva.
16. Xiang YH, Indra DE, Kalen LJ. Rapidly Growing
Mycobacteria: Clinical and Microbiologic Studies
of  115 Cases American Journal of  Clinical
Pathology. 2007; 128 (4), 612-621.
17. Shea YR,  Davis JL, Huang L, et al: High
Sensitivity and Specificity of Acid-Fast Microscopy
for Diagnosis of  Pulmonary Tuberculosis in an
African Population with a High Prevalence of
Human Immunodeficiency Virus_ J Clin
Microbiol, May 2009, 1553–1555 Vol. 47, No. 5.
18. Farnia P, Mohammadi F, Zarifi Z, et al:
Improving Sensitivity of Direct Microscopy for
Detection of Acid-Fast Bacilli in Sputum: Use of
Chitin in Mucus Digestion J Clin Microbiol. 2002
February; 40(2): 508–511.
